Literature DB >> 19317492

Macroscopic differences in HMGA oncoproteins post-translational modifications: C-terminal phosphorylation of HMGA2 affects its DNA binding properties.

Riccardo Sgarra1, Elisa Maurizio, Salvina Zammitti, Alessandra Lo Sardo, Vincenzo Giancotti, Guidalberto Manfioletti.   

Abstract

HMGA is a family of nuclear proteins involved in a huge number of functions at the chromatin level. It consists of three members, HMGA1a, HMGA1b, and HMGA2, having high sequence homology and sharing the same structural organization (three highly conserved DNA-binding domains, an acidic C-terminal tail, and a protein-protein interaction domain). They are considered important nodes in the chromatin context, establishing a complex network of interactions with both promoter/enhancer sequences and nuclear factors. They are involved in a plethora of biological processes and their activities are finely tuned by several different post-translational modifications. We have performed an LC/MS screening on several different cell lines to investigate HMGA proteins expression and their post-translational modifications in order to detect distinctive modification patterns for each. Our analyses evidenced relevant macroscopic differences in the phosphorylation and methylation patterns of these proteins. These differences occur both within the HMGA family members and in the different cell types. Focusing on HMGA2, we have mapped its in vivo phosphorylation sites demonstrating that, similarly to the HMGA1 proteins, it is highly phosphorylated on the acidic C-terminal tail and that these modifications affect its DNA binding properties.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19317492     DOI: 10.1021/pr900087r

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  16 in total

1.  Global phosphoproteome profiling reveals unanticipated networks responsive to cisplatin treatment of embryonic stem cells.

Authors:  Alex Pines; Christian D Kelstrup; Mischa G Vrouwe; Jordi C Puigvert; Dimitris Typas; Branislav Misovic; Anton de Groot; Louise von Stechow; Bob van de Water; Erik H J Danen; Harry Vrieling; Leon H F Mullenders; Jesper V Olsen
Journal:  Mol Cell Biol       Date:  2011-10-17       Impact factor: 4.272

2.  Stable isotope labeling of phosphoproteins for large-scale phosphorylation rate determination.

Authors:  Rosalynn C Molden; Jonathan Goya; Zia Khan; Benjamin A Garcia
Journal:  Mol Cell Proteomics       Date:  2014-02-16       Impact factor: 5.911

3.  Regulation of transcription factor Twist expression by the DNA architectural protein high mobility group A2 during epithelial-to-mesenchymal transition.

Authors:  E-Jean Tan; Sylvie Thuault; Laia Caja; Tea Carletti; Carl-Henrik Heldin; Aristidis Moustakas
Journal:  J Biol Chem       Date:  2012-01-11       Impact factor: 5.157

4.  Collective mass spectrometry approaches reveal broad and combinatorial modification of high mobility group protein A1a.

Authors:  Nicolas L Young; Mariana D Plazas-Mayorca; Peter A DiMaggio; Ian Z Flaniken; Andrea J Beltran; Neeli Mishra; Gary LeRoy; Christodoulos A Floudas; Benjamin A Garcia
Journal:  J Am Soc Mass Spectrom       Date:  2010-01-28       Impact factor: 3.109

Review 5.  Protein kinases: mechanisms and downstream targets in inflammation-mediated obesity and insulin resistance.

Authors:  Kalyana C Nandipati; Saravanan Subramanian; Devendra K Agrawal
Journal:  Mol Cell Biochem       Date:  2016-11-21       Impact factor: 3.396

Review 6.  HMG modifications and nuclear function.

Authors:  Qingchun Zhang; Yinsheng Wang
Journal:  Biochim Biophys Acta       Date:  2010 Jan-Feb

7.  Stromal epigenetic dysregulation is sufficient to initiate mouse prostate cancer via paracrine Wnt signaling.

Authors:  Yang Zong; Jiaoti Huang; Devipriya Sankarasharma; Teppei Morikawa; Masashi Fukayama; Jonathan I Epstein; Kiran K Chada; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-26       Impact factor: 11.205

8.  HMGA1 is a novel downstream nuclear target of the insulin receptor signaling pathway.

Authors:  Eusebio Chiefari; Maria T Nevolo; Biagio Arcidiacono; Elisa Maurizio; Aurora Nocera; Stefania Iiritano; Riccardo Sgarra; Katiuscia Possidente; Camillo Palmieri; Francesco Paonessa; Giuseppe Brunetti; Guidalberto Manfioletti; Daniela Foti; Antonio Brunetti
Journal:  Sci Rep       Date:  2012-02-07       Impact factor: 4.379

9.  A novel mechanism of post-translational modulation of HMGA functions by the histone chaperone nucleophosmin.

Authors:  Laura Arnoldo; Riccardo Sgarra; Eusebio Chiefari; Stefania Iiritano; Biagio Arcidiacono; Silvia Pegoraro; Ilenia Pellarin; Antonio Brunetti; Guidalberto Manfioletti
Journal:  Sci Rep       Date:  2015-02-25       Impact factor: 4.379

Review 10.  HMGA1-pseudogenes and cancer.

Authors:  Marco De Martino; Floriana Forzati; Claudio Arra; Alfredo Fusco; Francesco Esposito
Journal:  Oncotarget       Date:  2016-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.